Ask an Expert : Earn Credits: Modules @ BMJ Learning

Dear Readers..!!! Thanks for visiting my blog...!!!

Tanya is 33 and presents complaining of breakthrough bleeding with her contraceptive implant. It has been in situ for over two years and she has been getting altered bleeding for the last four months. She is up to date with her cervical cytology screening: her last one was taken 12 months ago and was normal. She had an STI screen six months ago and this was also normal.

How should you investigate and manage the patient in this scenario?

In this new module Ask an expert: Contraception in primary care

Dr Cindy Farmer offers expert answers to GPs’ questions on common practical challenges.

Key questions answered include:

• What is the latest evidence regarding long term safety of the contraceptive implant and injection on bone density?
• How important is family history when discussing contraception risks?
• Changes in bleeding are so common in women taking hormonal contraception. When and how should I investigate this?
• You can test your knowledge with case-based assessment questions at the end of the module and download a certificate of completion for your appraisal or training portfolio.

Other modules in the Ask an Expert series include:

Ask an expert: Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Ask an expert: Chronic heart failure

Ask an expert: Psoriasis

Various Accreditation programmes offered through BMJ Learning that would fetch some credits.

Accreditor	credit	Accreditation statement
ASCOFAME	1:00 hour	BMJ Learning has assigned 1 hour of CPD/CME credit to this module. BMJ Learning modules are being certified for ASCOFAME VIRTUAL (Colombia).
Australian College of Nursing	1 credit, 1:00 hour	ACN 3LP participants can claim 1 CNE point per hour of active learning for modules that are directly related to their area of nursing practice (no limit).
Austrian Academy of Physicians	1 credit, 1:00 hour	BMJ Learning modules have been certified for DFT Punkte. DFT Punkte are accepted in Austria
BMJ Learning	1 credit, 1:00 hour	BMJ Learning has assigned one hour of CPD/CME credit to the module and related journal article
Bahrain Defence Force Hospital	1 credit, 1:00 hour	The Bahrain Defence Force Military Hospital represented by the Ministry of Defence Bahrain recognises BMJ Learning as being accredited for the purpose of continuous medical education (CME)/continuous professional development (CPD) in BDF. Healthcare professionals can thus claim continuous professional development credits for their activity in BMJ Learning. Completion of one module is considered the equivalent of one credit or one hour of learning.
Bhutan Medical and Health Council	1 credit, 1:00 hour	Bhutan Medical and Health Council has formally accredited all BMJ Learning online modules for continuous professional development. Bhutan Medical and Health Council will accept the CME credit provided by BMJ Learning to any registered members of Bhutan Medical and Health Council for renewal of their registration.
Delhi Medical Council	1 credit, 1:00 hour	The Delhi Medical Council recognises BMJ Learning as being accredited for the purpose of continuous medical education (CME)/continuous professional development (CPD). Doctors can thus claim continuous professional development credits for their activity in BMJ Learning. Completion of one module is considered the equivalent of 1 credit or 1 hour of learning.
Dubai Health Authority	1 credit, 1:00 hour	BMJ Learning is approved as a CME resource by the Dubai Health Authority (accreditation number 0254/11)
Iraqi Ministry of Health	1 credit, 1:00 hour	The Iraq Ministry of Health has accredited BMJ Learning for the purposes of CME. One module is the equivalent of one hour or one credit point.
Kuwait Institute for Medical Specialization	1 credit, 1:00 hour	Kuwait Institute for Medical Specialization (KIMS) of the Ministry of Health, State of Kuwait is the authority responsible for organising all aspects of postgraduate training of medical practitioners and other health professionals in Kuwait. Users within Kuwait can claim one hour or one credit per hour of learning completed.
Oman Medical Specialty Board	0.5 credits	The Oman Medical Specialty Board accredits this module for 0.5 credit points under Category II
Royal Australasian College of Physicians	1:00 hour	The RACP does not accredit CPD activities, but MyCPD Program guidelines state that fellows can claim a maximum of 50 credits per year for online learning under 'Category 6 - Other Learning Activities'.
The Colleges of Medicine of South Africa	3 credits	The Colleges of Medicine of South Africa has accredited this BMJ Learning module (accreditation number: MDB014/254/06/2010)
The Royal New Zealand College of General Practitioners	1 credit, 1:00 hour	RNZCGP endorses the British Medical Journal online CME programmes
The Supreme Council of Health in Qatar	1 credit, 1:00 hour	The Supreme Council of Health represented by the Accreditation Department of the Qatar Council for Health Practitioners recognizes the continuous medical education (CME)/continuing professional development (CPD) modules provided through BMJ Learning as Category II self-directed learning activities in the State of Qatar. Healthcare professionals in Qatar can thus claim continuing professional development credits for their activity on BMJ Learning, calculated as 1 credit unit per 1 hour (Organization Code OP-02).
Trinidad and Tobago Medical Association	0.5 credits, 1:00 hour	The Trinidad and Tobago Medical Association has accredited BMJ Learning. One module equates to 0.5 credits.

For more Updates, follow us on Facebook. 

Happy Blogging...!!!

Regards,

Deepak Kumar Bandari,

Pharm.D Intern,

Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

Bacteriology and Classification of Antibiotics : An Overview

Dear Readers..!!! Thanks for visiting my blog...!!!

Source : Unknown

CLASSIFICATION OF ANTIBIOTICS – SPECTRUM OF ACTIVITY

NARROW	INTERMEDIATE	BROAD
Penicillin G	Aminopenicillins	Tetracyclines
Streptomycin	Cephalosporins (2/3rd generations)	Chloramphenicol
Erythromycin	Fluoroquinolones
	Newer macrolides

CLASSIFICATION OF ANTIBIOTICS – TYPE OF ACTION

BACTERIOSTATIC	BACTERIOCIDAL
Sulfonamides	Penicillins
Tetracyclines	Aminoglycosides
Chloramphenicol	Polypeptides
Erythromycin	Rifampin
Ethambutol	Cotrimoxazole
Clindamycin	Isoniazid
Linazolid	Cephalosporins
	Vancomycin
	Nalidixic acid
	Ciprofloxacin
	Metronidazole
	Pyrazinamide

CEPHALOSPORINS

Generation	Parenteral	Oral
First	Cephalothin Cefazolin	Cephalexin Cephradine Cefadroxil
Second	Cefuroxime Cefoxitin	Cefaclor Cefuroxime axetil Cefprozil
Third	Cefotaxime Ceftizoxime Ceftriaxone Ceftazidime Cefoperazone	Cefixime Cefpodoxime proxetil Cefdinir Ceftibuten Ceftamet pivoxil
Fourth	Cefepime Cefpirome
Fifth	Ceftobiprole Ceftaroline Ceftolozane

For more Updates, follow us on Facebook. 

Happy Blogging...!!!

Regards,

Deepak Kumar Bandari,

Pharm.D Intern,

Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

Woman behind every smile of a Cancer Patient : Salute Her

Dear Readers..!!! Thanks for visiting my blog...!!!

Today I would like to introduce you Her Excellency Prof. Dr. Gayatri Palat, MD - "a woman behind every smile of a cancer patient". Indeed its my privilege to be a trainee under the guidance of the team led by her. This team of MNJ institute of Oncology, INCTR, Pallium India and Two Worlds Cancer Collaboration has entirely changed my views and perceptions of Palliative care and approach towards the patient. The handwork, dedication, moral support and ethical approach shown by every member of the team is immense and they have once again proved how a team work can do miracles by bringing smiles in patients even at their end stage of life. 

Palliative Care for Children in a Resource Poor Setting, an Indian initiative

In Her words: 

Today, a child diagnosed with cancer in a developed country has an 80% chance of being cured. Unfortunately, this is not true in India where 75,000 children with recorded cancers each year have a survival rate of less than 20%. Furthermore, of the estimated 2.5 million people in India living with HIV/AIDS, 70,000 are children under the age of 15. Less than 0.4% of needy children have access to palliative care programs designed to address their needs.

Palliative Care for Children in the Mehdi Nawaj Jung (MNJ) Institute of Oncology (MNJIO), Hyderabad 

The MNJ Institute of Oncology is a 300 bed tertiary care hospital in the state of Andhra Pradesh, India (population of 65 million). Every year the hospital sees around 1,000 children with cancer.Most of the children require long, intensive curative treatment. Enormous suffering results from painful procedures, undesirable symptoms and the emotional trauma of facing potentially life threatening illnesses. Many children develop severe anxiety, depression and become withdrawn and non-communicative. Families often travel long distances and stay in the hospital for weeks and when the need for community and family support is greatest, they are totally deprived of it. Very early in our endeavour to cure these children, we realized the dire need for an effective palliative care program for both the children and their families as they confront cancer with all of its physical, psychosocial and spiritual effects. 

MNJIO Pain Relief and Palliative Care Program, a collaboration of the International Network for Cancer Treatment and Research (INCTR) and Pallium India added paediatric palliative care to their service in 2007. The primary goal of the program is zero-tolerance of pain beginning at diagnosis. Since the paediatric program was established, there has been a rapid increase in the number of children treated beginning with 69 patient visits in 2006 and 2,922 in 2010 ( Fig 1). 70% of children suffered from leukaemia and pain was the most common symptom at referral. Other common symptoms included mouth ulcers, constipation, vomiting and tiredness. The total opioid consumption for the year 2010 was 150gms. Every child undergoing interventions such as intrathecal or bone marrow injections received EMLA cream application +/- oral midazolam before the procedure. Other activities included regular weekly support groups, recreational and educational activities, home based care and regular and emergency telephonic consults.

A few successful outcomes of the program have been: 

• almost all children receiving cancer treatment and their families are also receiving adequate symptom control and psychosocial support during curative treatment along with a smooth transition to end of life care if required, 
• there has been a significant reduction in the dropout rate during treatment, and 
• there is good implementation of procedure-related pain relief protocols. 

Scope of the program:

The paediatric pain and palliative care program is the first of its kind for the entire state of Andhra Pradesh. While the program is currently designed to cater only to the needs of children with cancer, we plan to expand it to include all children living with HIV and AIDS and other life threatening illnesses. A fellowship course in paediatric palliative care will start soon to train specialists in the field.

Hypertension : Explained Clearly by World class Instructors

Dear Readers..!!! Thanks for visiting my blog...!!!

Click on the image to view clearly

JNC - VIII Evidence Based Guidelines

For more Updates, follow us on Facebook. 

Happy Blogging...!!!

Regards,

Deepak Kumar Bandari,

Pharm.D Intern,

Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

Psychological Distress in Cancer : Workshop @ IIT Hyderabad

Dear Readers..!!! Thanks for visiting my blog...!!!

Download the Brochure Here

For more Updates, follow us on Facebook. 

Happy Blogging...!!!

Regards,

Deepak Kumar Bandari,

Pharm.D Intern,

Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

Clinical Data Manager in Novartis : B.Pharm

Dear Readers..!!! Thanks for visiting my blog...!!!

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Clinical Data Manager

Job Description: Provide timely and professional ongoing management of clinical trial data with respect to cost, quality and timelines for assigned trials managed within Clinical Data Management. Ensure consistently high quality data available for analysis and reporting.

1. As Clinical Data Manager (CDM) provide data management input on Clinical Trial Teams. May have the role of TDM on small, low complexity trials

2. Reviews and contributes to preparation of protocols, specifically related to the Visit Evaluation Schedule (VES), Study Design and Data Management section

3. Gives input to Data Handling Plan (DHP) and Data Review Plan (DRP) for assigned trials. Responsible for the development of these documents if assigned the role of Trial Data Manager (TDM)

4. Participates in the preparation of training materials for investigator meetings

5. Disseminates study-level information either to the TDM (if assigned to a trial as a Data Manager) or to the Clinical Trial Team (CTT) & Program Clinical Data Manager (PCDM) if assigned the role of TDM

6. Performs DM activities for start-up of a study including preparing the eCRF, CCGs, DHPs, DRPs and performing User Acceptance Testing (UAT) if required

7. Obtains input from study team members on the design of clinical databases while ensur-ing data quality and compliance with SOPs (if assigned the role of TDM)

8. Under supervision from PCDM (or delegate), ensures consistency of assigned trials with program level standards (DHPs, DRPs & eCRFs) Prepares final study documentation.

9. Performs ongoing review of all data generated from the clinical study including central and local lab data and coding

10. Interacts with the study team members to define the necessary listings needed to support data validation

11. Performs review of listings for quality, content, format and output

12. Identifies possible trends in data Leads and participates in the final review of all data generated from the clinical study

13. Participates in the preparation (if assigned as DM level) or prepare final study documentation

14. Performs final review of listings for quality, content, format and output

15. Performs activities necessary for database finalization and adhering to the timelines es-tablished by the study team

16. Verifies and tracks eCRF/CRF completion and provide data status updates

17. Ensures appropriate Novartis tracking systems are up to date and accurate

18. Actively participates at the study team level

19. Utilizes status and metric reports to identify training needs and issues with investigator sites

20. Gathers requirements for third party data

21. Maintains effective working relationships with Contract Research Organization (CRO) and other vendors as required

Candidate Profile: University or college degree in life science, computer science, pharmacy, nursing or equivalent relevant degree Fluent English (oral and written). Ideally 3 years’ experience in Drug Development with at least 2 years in Clinical Data Management

Additional Information:

Location: Hyderabad

Industry Type: Pharma/ Biotech/Clinical Research

Functional Area: R&D

End Date: 25th January, 2016

Apply Here

For more Updates, follow us on Facebook. 

Happy Blogging...!!!

Regards,

Deepak Kumar Bandari,

Pharm.D Intern,

Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia

Vacancy in Drug resistant Breast Cancer project at NIN

Dear Readers..!!! Thanks for visiting my blog...!!!

NIN has attained global recognition for its pioneering studies on various aspects of nutrition research, with special reference to protein energy malnutrition (PEM). Institute’s activities are broad-based, encompassing the whole area of food and nutrition. The Institute has achieved close integration in its research activities between the laboratory, the clinic and the community.

Name of the post/ position: Junior Research Fellow

Eligible candidates are invited to apply for the following post/ position on the ad hoc research project entitled: "Drug resistant Breast Cancer Cells to understand Cancer Stem Cells metabolism and therapy" funded by DBT at this Institute.

Applications will be received from the individuals on 5th January, 2016 between 9:30 A.M. and 10:30 A.M. at Conference Hall, NIN, Tarnaka, Hyderabad. Late applications will not be entertained after 10:30 A M under any circumstances. The Candidates may download Application form from NIN website.

The essential qualification, experience, consolidated Pay and service tenure are as under:

Essential Qualifications: Post Graduate Degree in Basic Science with NET qualification or Graduate Degree in Professional Course with NET qualification or Post Graduate Degree in Pharmacy from recognized University.

Desirable: Masters in Pharmacy or Bachelor in Pharmacy with GATE or GPAT exam qualifying score or M.Sc. in Biochemistry/ Biotechnology/ Life Science with NET qualifying score.

Age: Below 30 years. Relaxation of age is admissible as per G O.I. Rules.

Consolidated Stipend/ Emoluments: Rs. 12,000.00 + 30% HRA per month fixed without any other allowances.

Tenure: Initially for one year and extendable based on performance and funds position.

Date & Time of Written Test/ Interview: 5th January, 2016 from 9:30 A.M. onwards.

The shortlisted candidates should bring all original certificates of educational qualification (from SSC onwards), experience, SC/ST/OBC Community Certificate/ PH Certificates along with a pass port size photograph and set of Photo copies duly attested for attending the Written Test/ Interview. The persons belonging to Other Backward Category should bring the latest O.B.C. (Non-creamy layer) Certificate issued by the respective Tahsildar/ MRO specifically issued for the purpose of applying for Central Government Post. No TA/ DA will be paid for attending the Written Test/ Interview.

GENERAL CONDITIONS: The conditions of employment will be the same as that for the project staff on contract basis. The candidates have no right to claim for any regular employment at this Institute. The Director in-charge & Appointing Authority has the right to accept/ reject any application without assigning any reason/s and no correspondence in this matter will be entertained. Age, experience etc., will be reckoned as on 14 12.2015.

Selection Procedure: Written test/Interview will be conducted to the eligible candidates, if the large numbers of candidates are found to be eligible in the screening. If the lesser number of candidates are found to be eligible in the screening, interview will be conducted only to the eligible candidates for final selection. If written test is conducted, the names of the shortlisted candidates will be displayed on the Notice Board, which is kept in front of the Conference Hall on the same day.

Note: The applications will not be accepted by post/ courier.

For more Updates, follow us on Facebook. 

Happy Blogging...!!!

Regards,

Deepak Kumar Bandari,

Pharm.D Intern,

Vaagdevi College of Pharmacy - India

Elsevier Student Ambassador - South Asia